Articles in Scholarly Journals [Incomplete List]

1. Proteasome inhibitors: antitumor effects and beyond
   Leukemia, vol. 21, no. 1, Article ID 2404444, 6 pages, 2007
2. Histone Deacetylase Inhibitors Affect Dendritic Cell Differentiation and Immunogenicity
   Clinical Cancer Research, vol. 13, no. 13, pp. 3933–3941, 2007
3. Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation
   Blood, vol. 108, no. 2, pp. 551–558, 2006
4. Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells
   European Journal of Immunology, vol. 36, no. 3, pp. 681–689, 2006
5. Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase
   Cardiovascular Research, vol. 69, no. 3, pp. 736–745, 2006
6. Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study
   British Journal of Cancer, vol. 94, no. 7, Article ID 6603060, 4 pages, 2006
7. Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer
   British Journal of Cancer, vol. 92, no. 10, Article ID 6602563, 4 pages, 2005
8. Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer
   The Lancet, vol. 366, no. 9482, pp. 318–320, 2005
9. Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis
   Blood, vol. 105, no. 8, pp. 3255–3262, 2005
10. Cooperative Cytotoxicity of Proteasome Inhibitors and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Chemoresistant Bcl-2-Overexpressing Cells
    Clinical Cancer Research, vol. 11, no. 11, pp. 4259–4265, 2005
11. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Cooperates with Anticancer Drugs to Overcome Chemoresistance in Antiapoptotic Bcl-2 Family Members Expressing Jurkat Cells
    Clinical Cancer Research, vol. 10, no. 4, pp. 1463–1470, 2004
12. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro
    Journal of Molecular and Cellular Cardiology, vol. 37, no. 4, pp. 837–846, 2004
13. Dose-dense Vinorelbine and Paclitaxel with Granulocyte Colony-stimulating Factor in Metastatic Breast Cancer Patients: Anti-tumor Activity and Peripheral Blood Progenitor Cell Mobilization Capability
    Breast Cancer Research and Treatment, vol. 82, no. 3, pp. 185–190, 2003
14. Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer
    Cancer Gene Therapy, vol. 10, no. 3, Article ID 7700557, 5 pages, 2003
15. Autologous peripheral blood stem cells (PBSC) in breast cancer
    Transfusion and Apheresis Science, vol. 27, no. 2, pp. 167–173, 2002
16. Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma
    European Journal of Haematology, vol. 68, no. 2, pp. 101–106, 2002
17. Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination
    Cancer, vol. 92, no. 8, pp. 2030–2035, 2001
18. Adjuvant Chemotherapy with High-Dose Cyclophosphamide, Etoposide and Cisplatin Intensification without Progenitor Cell Support in Breast Cancer Patients with Ten or More Involved Nodes: 5-Year Results of a Pilot Trial
    Oncology, vol. 60, no. 3, pp. 221–227, 2001
19. Effects of Three Cytokine Regimens on Hematologic Recovery and Progenitor Cell Mobilization after High-Dose Cyclophosphamide, Etoposide, and Cisplatin
    Oncology, vol. 59, no. 1, pp. 7–13, 2000
20. The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer
    Cancer Immunology, Immunotherapy, vol. 48, no. 6, pp. 287–296, 1999
21. High frequency of trisomy 8 in acute promyelocytic leukemia: A fluorescence in situ hybridization study
    Cancer Genetics and Cytogenetics, vol. 97, no. 2, pp. 161–164, 1997
22. Standard-Dose Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) Allows Safe and Repeated Administration of High-Dose Cyclophosphamide, Etoposide, and Cisplatin (CEP)
    American Journal of Clinical Oncology, vol. 20, no. 3, pp. 266–271, 1997
23. Specific conjunctival challenge in polysensitized subjects
    Allergy, vol. 52, no. 9, pp. 960–961, 1997
24. Necrotizing eccrine squamous syringometaplasia presenting as acral erythema
    Journal of Cutaneous Pathology, vol. 18, no. 6, pp. 453–456, 1991
25. Tumor cell lysis by activated human neutrophils: Analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1
    Inflammation, vol. 15, no. 1, pp. 15–30, 1991
26. Expression of cytolytic functions in HL-60 leukaemic cells after induction of polymorphonuclear leukocyte differentiation
    Blut, vol. 52, no. 4, pp. 243–248, 1986
27. Cellular cytotoxicity mediated by granule-depleted neutrophil cytoplasts
    Blut, vol. 51, no. 2, pp. 97–102, 1985